These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 12473799
1. Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies. Honey E, Augood C, Templeton A, Russell I, Paavonen J, Mårdh PA, Stary A, Stray-Pedersen B. Sex Transm Infect; 2002 Dec; 78(6):406-12. PubMed ID: 12473799 [Abstract] [Full Text] [Related]
2. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses. van Valkengoed IG, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ. Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651 [Abstract] [Full Text] [Related]
4. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. Howell MR, Gaydos JC, McKee KT, Quinn TC, Gaydos CA. Sex Transm Dis; 1999 Oct; 26(9):519-26. PubMed ID: 10534206 [Abstract] [Full Text] [Related]
6. Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens. van Valkengoed IG, Postma MJ, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ. Sex Transm Infect; 2001 Aug; 77(4):276-82. PubMed ID: 11463928 [Abstract] [Full Text] [Related]
8. Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Howell MR, Quinn TC, Brathwaite W, Gaydos CA. Sex Transm Dis; 1998 Feb; 25(2):108-17. PubMed ID: 9518379 [Abstract] [Full Text] [Related]
9. Developments in the screening for Chlamydia trachomatis: a review. Kohl KS, Markowitz LE, Koumans EH. Obstet Gynecol Clin North Am; 2003 Dec; 30(4):637-58. PubMed ID: 14719842 [Abstract] [Full Text] [Related]
12. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women]. Postma MJ, Welte R, van den Hoek JA, van Doornum GJ, Coutinho RA, Jager JC. Ned Tijdschr Geneeskd; 1999 Mar 27; 143(13):677-81. PubMed ID: 10321301 [Abstract] [Full Text] [Related]
13. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Howell MR, Quinn TC, Gaydos CA. Ann Intern Med; 1998 Feb 15; 128(4):277-84. PubMed ID: 9471930 [Abstract] [Full Text] [Related]
14. Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis. Postma MJ, Welte R, van den Hoek JA, van Doornum GJ, Jager HC, Coutinho RA. Value Health; 2001 Feb 15; 4(3):266-75. PubMed ID: 11705188 [Abstract] [Full Text] [Related]
17. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more]. Postma MJ, Bakker A, Welte R, van Bergen JE, van den Hoek JA, de Jong-van den Berg LT, Jager JC. Ned Tijdschr Geneeskd; 2000 Dec 02; 144(49):2350-4. PubMed ID: 11129971 [Abstract] [Full Text] [Related]
19. Cost-effectiveness of screening swab or urine specimens for Chlamydia trachomatis from young Canadian women in Ontario. Goeree R, Jang D, Blackhouse G, Chong S, Mahony J, Sellors J, Foy A, Chernesky M. Sex Transm Dis; 2001 Dec 02; 28(12):701-9. PubMed ID: 11725225 [Abstract] [Full Text] [Related]